期刊文献+

人血小板源性生长因子A基因发夹结构小干扰RNA真核表达载体的构建及鉴定

Establishment and identification of small hairpin interfering RNA eukaryotic expression vectors of human platelet-derived growth factor A
下载PDF
导出
摘要 目的:血小板源性生长因子对诱发视网膜色素上皮细胞移行、最终导致增生性玻璃体视网膜病变起到了重要作用。构建人血小板源性生长因子A具有发夹结构小干扰RNA(shRNA)表达质粒,以观察其对人血小板源性生长因子A基因表达的沉默效果。方法:实验于2007-04/2007-07在吉林大学第一临床医院传染科研究室完成。根据血小板源性生长因子A基因mRNA序列,设计有小发夹结构的3条寡核苷酸序列,克隆到空载体pGPU6/GFP/Neo中,构建重组质粒,同时设计构建分别针对人GAPDH干扰质粒作为阳性对照,不针对任何特异基因的质粒作为阴性对照。通过酶切鉴定和测序验证阳性克隆。结果:经重组质粒筛选,重组质粒测序鉴定与设计的shRNA转录模板序列相同,均证实重组质粒构建成功。结论:利用RNA干扰技术路线可成功构建靶向人血小板源性生长因子A的发夹结构小干扰RNA表达载体。 AIM: Platelet-derived growth factor (PDGF)-A plays an important role in leading to proliferative vitreous retinopathy through inducing the migration of retinal pigment epithelium. This study was designed to establish the recombinant plasmid of small hairpin interfering RNA (shRNA) against human PDGF-A and observe silence effect of the human PDGF-A expression. METHODS: The experiment was conducted at the Infection Laboratory of the First Affiliated Hospital of Jilin University from April to July in 2007. Recombinant plasmid was constructed based on human PDGF-A mRNA sequence. Three pairs of oligo nucleotides were synthesized and inserted into plasmid pGPU6/GFP/Neo to generate shRNA eukaryotic expression vectors. Interfering plasmid from GAPDH were established as positive control and interfering plasmid targeting none gene served as negative control. The recombinant were verified by enzyme digestion and sequencing. RESULTS: The recombinant plasmid sequence was the same as the sequence of shRNA transcribed sequence. So the recombinant vectors were established successfully. CONCLUSION: The shRNA expression vector targeting human PDGF-A can be established successfully by RNA interference technique.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2007年第46期9289-9292,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献18

  • 1Charteris DG. Proliferative vitreoretinopathy: pathobiology, surgical, management and adjunctive treatment.Br J Ophthalmology 1995,79(10):953-960.
  • 2Carrington L, Mcleod D, Boulton M. IL-10 and antibodies to TGF-beta2 and PDGF inhibit RPE-mediated retinal contraction.Invest Ophthalmol Vis Sci 2000,41(5):1210-1216.
  • 3Campochiaro PA. Pathogenic mechanisms in proliferative vitreo-retinopathy. Arch Ophthalmol 1997,115:237-241.
  • 4Cui JZ, Chiu A, Maberley D, et al.Stage specificity of novel growth factor expression during development of proliferative vitreoretinopathy. Eye 2007,21:200-208.
  • 5Spraul CW, Kaven C, Lang GK, et al.Effect of growth factors on bovine retinal pigment epithelial cell migration and proliferation.Ophthalmic Res 2004,36(3): 166-171.
  • 6Hollborn M, Reichenbach A, Wiedemann P, et al.Contrary effects of cytokines on mRNAs of cell cycle-and ECM-related proteins in hRPE cells in vitro. Curr Eve Res 2004,28(3):215-223.
  • 7Ren G, Fuse N, Abe T, et al. mRNA expression of proto-oncogenes and platelet-dedved growth factor in proliferative vitreoretinal diseases. Jpn J Ophthalmol 2000,44(3): 308-311.
  • 8Endo H, Naito T, Asahara T, et aI.Cytokines in the vitreous fluid proliferative diabetic retinopathy-vascular endothelial growth factor and growth factor are elevated in proliferative diabetic retinopathy. Nippon Ganka Gakkai Zasshi 2000,104(10): 711-716.
  • 9Freyberger H, Brocker M, Yakut H, et al. Increased levels of platelet-derived growth factor in vitreous fluid of patients with proliferative diabetic retinopathy. Exp Clin Endocrinol Diabetes 2000,108(2):06-109.
  • 10司艳芳,惠延年,关娟,王君,陈丹,杜红俊.血小板源性生长因子对人视网膜色素上皮细胞表达肌动蛋白的影响[J].中华眼底病杂志,2003,19(4):241-243. 被引量:15

二级参考文献1

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部